公司资料
Incannex Healthcare 股价、新闻与催化剂
- 股票代码:
- IXHL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Australia and listed in the U
股票表现
3.25 USD (+0.31%)
收盘价
最后更新: 2026年10月1日
36.5M USD
市值
股价为何变动
截至 2026年10月1日，IXHL 上涨 0.31%，收于 $3.25。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Incannex Healthcare is a biotechnology company focused on cannabinoid-based and related therapies for inflammatory and sleep disorders. Its story is centered on translating cannabinoid science into specialty treatments.
所在地与行业分类
Incannex is headquartered in Australia and listed in the U.S. market. It sits in specialty biotechnology with a cannabinoid and inflammation focus.
商业模式特征
The company depends on clinical data, regulatory progress, and capital efficiency while it develops a narrow pipeline. Investors watch early signals and commercialization potential.
生物医药行业定位
Incannex occupies a niche cannabinoid-biotech position. The stock is catalyst-sensitive because the company still needs to prove its therapeutic thesis in the clinic.
未来催化剂
- Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive. The stock remains highly event-driven.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。